Identification and characterization of the high affinity vascular angiotensin II receptor in rat mesenteric artery.
- 1 August 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 47 (2) , 278-286
- https://doi.org/10.1161/01.res.47.2.278
Abstract
To study the physiology of the high affinity vascular smooth muscle receptor for angiotensin II [A], 125I-A binding sites were characterized in a particulate fraction prepared from rat mesenteric arteries. 125I-A binding was saturable at physiological concentrations of hormone and was of high affinity. Scatchard analysis indicated a single class of binding sites with an Kd of 0.91 .+-. 0.11 (SD) nM, and a total binding capacity of 53.7 .+-. 3.0 f[femto]mol/mg protein. Parallel studies with 3H-A yielded a similar Kd (1.18 .+-. 0.48 nM) and total binding capacity (56.8 .+-. 9.2 fmol/mg protein). 125I-A associated with binding sites rapidly (half-time for association = 4 min at 37.degree. C), and reversibly. Kinetic analysis of binding at 22.degree. C by 2 independent methods yielded comparable values for both the association rate (4.0 and 6.8 .times. 105/M per s) and dissociation rate (3.2 and 3.8 .times. 10-4/s) constants. Kd calculated from kinetic analysis (0.56 and 0.80 nM) were in close agreement with those obtained from steady state Scatchard analysis. Analogs and antagonists of A competed for binding in a potency series which exactly paralleled that observed for bioassay systems utilizing pressor response in vivo and vascular smooth muscle contraction in vitro. 125I-A binding was stimulated 2- to 3-fold in the presence of 1 mM divalent cations (Mn2+ > Mg2+ > Ca2+) and reversibly inhibited by EDTA and ethylene glycol-bis(.beta.-aminoethyl ether)N,N,N'',N''-tetraacetic acid. Dithiothreitol (5 mM), a sulfhydryl-reducing agent that was reported to block vasoconstrictor response to A, inhibited 125I binding by 45%. The present study defines specific A binding sites in a muscular artery representative of the resistance vasculature. These binding sites, unlike those previously described in conductance-type vessels (aorta), apparently have a sufficiently high affinity to interact with physiological levels of hormone.This publication has 24 references indexed in Scilit:
- Offset of actions of angiotensin II, angiotensin III, and their analogue antagonists in renal and femoral vascular beds: Further evidence for different vascular angiotensin receptorsLife Sciences, 1979
- Ca2 + and Mg 2+ dependence of angiotensin II binding to isolated rat renal glomeruliBiochemical Pharmacology, 1978
- Variations in the number of uterine angiotensin receptors following changes in plasma angiotensin levelsEuropean Journal of Pharmacology, 1976
- RADIOIMMUNOASSAY OF ANGIOTENSIN II IN THE RATJournal of Endocrinology, 1976
- Vascular reactivity to noradrenaline, potassium chloride, and angiotensin II in the rat perfused mesenteric vasculature preparation, during the development of renal hypertensionCardiovascular Research, 1975
- Evidence for renal glomerular receptors for angiotensin IIKidney International, 1974
- Application of Drug–Receptor Theories to AngiotensinCanadian Journal of Physiology and Pharmacology, 1973
- Calcium Release induced by Interaction of Angiotensin with its Receptors in Smooth Muscle Cell MicrosomesNature, 1972
- Angiotensin II Vascular Receptors: Their Avidity in Relationship to Sodium Balance, the Autonomic Nervous System, and HypertensionJournal of Clinical Investigation, 1972
- Preparation and properties of iodinated angiotensinsBiochemical Pharmacology, 1970